<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03333642</url>
  </required_header>
  <id_info>
    <org_study_id>67955917.2.0000.5253</org_study_id>
    <nct_id>NCT03333642</nct_id>
  </id_info>
  <brief_title>Surgery Treatment of Type 2 Diabetes Mellitus Patients With Grade 1 Obesity and Overweight</brief_title>
  <official_title>Ileal Interposition With Sleeve Gastrectomy for Type 2 Diabetes Mellitus Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Federal de Bonsucesso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Federal de Bonsucesso</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluate the Duodenal Ileal Interposition with Sleeve Gastrectomy for Type 2
      Diabetes Mellitus in grade 1 obesity and overweight patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A clinical trial, 1-arm treatment (Duodenal Ileal Interposition with Sleeve Gastrectomy for
      Type 2 Diabetes Mellitus), including 50 research subjects with type 2 diabetes mellitus and
      obesity class I or overweight. The main objective is to analyse the effect on glycemic
      control after 2 years of follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 27, 2017</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Remission of type 2 Diabetes at 24 months</measure>
    <time_frame>2 years</time_frame>
    <description>Number of patients with glycated hemoglobin (HbA1c) of 6.0% or less, without use of diabetes medications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Control of type 2 diabetes</measure>
    <time_frame>2 years</time_frame>
    <description>Number of patients with glycated hemoglobin (HbA1c) &lt; 6.5%, but still in use of oral anti diabetic drugs and/or insulin</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality of life assessment</measure>
    <time_frame>Before and 1, 3, 6, 12, 18 and 24 months after surgery</time_frame>
    <description>Application of World Health Organization's Quality of Life questionnaire (WHOQOL-BREF)</description>
  </other_outcome>
  <other_outcome>
    <measure>Measurement of surgical adverse events</measure>
    <time_frame>2 years</time_frame>
    <description>Use of Clavien-Dindo classification</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Obesity</condition>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Duodenal Ileal interposition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Duodenal Ileal Interposition with Sleeve Gastrectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Duodenal Ileal Interposition with Sleeve Gastrectomy</intervention_name>
    <description>Laparoscopic or open Duodenal Ileal Interposition with Sleeve Gastrectomy</description>
    <arm_group_label>Duodenal Ileal interposition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Documented diagnosis of type 2 diabetes mellitus;

          -  Patients of both sexes treated with oral antidiabetic agents and / or insulins,

          -  Stable antidiabetic medication in the last 8 weeks prior to selection, if the therapy
             includes insulin, the mean daily dose should not have been changed by more than 10% in
             the last 8 weeks;

          -  HbA1c&gt; 7.0%;

          -  Age&gt; 20 years and &lt;65 years;

          -  Body mass index (BMI) of 25 to 35 kg / m²;

          -  Agree to sign the consent form;

        Exclusion Criteria:

          -  Diabetes mellitus type 1 (anti-glutamic acid decarboxylase(GAD) positive) or anti-GAD
             negative body with low β-cell function (peptide C after stimulation &lt;0.5 ng / ml);

          -  Recent vascular event (myocardial infarction, coronary angioplasty or encephalic
             vascular accident in the last 6 months);

          -  Malignant neoplasm;

          -  Portal hypertension;

          -  Difficulty to cooperate with segment;

          -  Low ability to understand surgery;

          -  Unrealistic expectations of results;

          -  Cognitive deficit;

          -  Current pregnancy;

          -  Moderate or severe mood disorder; severe anxiety; eating disorders (based on
             Substance-Related Disorders DSM-V criteria);

          -  Chemical dependence or alcoholism (based on Substance-Related Disorders DSM-V
             criteria).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leonardo R Ferraz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Federal de Bonsucesso</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leonardo R Ferraz, MD</last_name>
    <phone>+55 21 996462422</phone>
    <email>lrferraz1@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Thiago B de Abreu, MD</last_name>
    <phone>+55 21 996487500</phone>
    <email>boechat11@yahoo.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Federal de Bonsucesso</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>21041-020</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leonardo R Ferraz, MD</last_name>
      <phone>+55 21 996462422</phone>
      <email>lrferraz1@1hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Thiago B Abreu, MD</last_name>
      <phone>+55 21 996487500</phone>
      <email>boechat1@yahoo.com.br</email>
    </contact_backup>
    <investigator>
      <last_name>Miguel Madeira, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luciana El Kadre, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aureo L de Paula, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2017</study_first_submitted>
  <study_first_submitted_qc>November 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2017</study_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Federal de Bonsucesso</investigator_affiliation>
    <investigator_full_name>Leonardo Rocha Ferraz</investigator_full_name>
    <investigator_title>Surgeon MD</investigator_title>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>metabolic surgery</keyword>
  <keyword>ileal interposition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

